{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-060794","form_type":"8-K","ticker":"AVIR","cik":"0001593899","company_name":"Atea Pharmaceuticals, Inc.","filed_at":"2025-03-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.110262+00:00","generated_at":"2026-05-24T06:33:24.630432+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Atea Pharmaceuticals receives director nominations from two stockholders for 2025 Annual Meeting","bullets":["Bradley L. Radoff nominates Howard H. Berman, James P. Flynn, and Michael Torok.","Driver Opportunity Partners III LP nominates J. Abbott R. Cooper for election.","Nominating Committee will evaluate candidates; formal recommendation in proxy statement.","No shareholder action required now; 2025 Annual Meeting date not yet scheduled.","Evercore and Latham & Watkins retained as financial and legal advisors."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-060794","json":"https://secwatch.observer/filing/0001193125-25-060794.json","markdown":"https://secwatch.observer/filing/0001193125-25-060794.md","text":"https://secwatch.observer/filing/0001193125-25-060794.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1593899/000119312525060794/0001193125-25-060794-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1593899/000119312525060794/d932774d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T06:33:24.630432+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}